The clinical efficacy and efficiency of a 100-IU starting dose of recombinant follicle stimulating hormone (Puregon®) in Korean women undergoing in vitro fertilization and embryo transfer

Journal of Obstetrics and Gynaecology Research

Volumn 29, Issue 3, 2003, Pages 174-179

  Moon, Shin Yong ^a   Kim, Seok Hyun ^a   Ku, Seung Yup ^a   Jee, Byoung Chul ^a   Choi, Young Min ^a   Lee, Jin Yong ^a  

^a Seoul National University   (South Korea)

Author keywords

100 IU starting dose; Controlled ovarian hyperstimulation; IVF; Recombinant human follicle stimulating hormone

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; GONADORELIN AGONIST; GONADOTROPIN; PROGESTERONE; RECOMBINANT FOLLITROPIN; TRIPTORELIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CRYOPRESERVATION; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; EMBRYO TRANSFER; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; INJECTION PAIN; INTRACYTOPLASMIC SPERM INJECTION; OOCYTE; OOCYTE MATURATION; OVARY HYPERSTIMULATION; PREGNANCY; PROSPECTIVE STUDY; TREATMENT OUTCOME; TWIN PREGNANCY;

ADULT; EMBRYO IMPLANTATION; EMBRYO TRANSFER; ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; FOLLICLE STIMULATING HORMONE, HUMAN; HUMANS; KOREA; OOCYTES; PREGNANCY; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; SPERM INJECTIONS, INTRACYTOPLASMIC; TISSUE AND ORGAN HARVESTING; TREATMENT OUTCOME;

EID: 0038644256     PISSN: 13418076     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1341-8076.2003.00096.x     Document Type: Article

References (11)

1. Porter RN, Smith W, Craft IL, Abdulwahid NA, Jacobs HS. Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins. Lancet 1984; 2: 1284-1285.
2. Olijve W, De Boer W, Mulders JW, Van Wezenbeek PM. Molecular biology and biochemistry of human recombinant follicle stimulating hormone (Puregon). Mol Hum Reprod 1996; 2: 371-382.
3. Out HJ, Mannaerts BM, Driessen SG, Bennink HJ. A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization. Hum Reprod 1995; 10: 2534-2540.
4. Coelingh Bennink HJ, Fauser BC, Out HJ. Recombinant follicle-stimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene citrate-resistant, normogonadotropic, chronic anovulation: A prospective, multicenter, assessor-blind, randomized, clinical trial. European Puregon Collaborative Anovulation Study Group. Fertil Steril 1998; 69: 19-25.
5. Raga F, Bonilla-Musoles F, Casan EM, Bonilla F. Recombinant follicle stimulating hormone stimulation in poor responders with normal basal concentrations of follicle stimulating hormone and oestradiol: Improved reproductive outcome. Hum Reprod 1999; 14: 1431-1434.
6. Balasch J, Fabregues F, Creus M et al. Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women undergoing ovarian stimulation after pituitary suppression for in vitro fertilization: Implications for implantation potential. J Assist Reprod Genet 2000; 17: 20-27.
7. Staessen C, Camus M, Khan I et al. An 18-month survey of infertility treatment by in vitro fertilization, gamete and zygote intrafallopian transfer, and replacement of frozen-thawed embryos. J Vitro Fert Embryo Transf 1989; 6: 22-29.
8. Camier B, Avril C, Cohen J. A multicentre, prospective, randomised study to compare a low dose protocol versus conventional administration of recombinant human follicle stimulating hormone (Gonal-F®) in normo-responder women undergoing IVF/ICSI (Abstract). 14th Annual Meeting of the European Society of Human Reproduction and Embryology, Gothenburg, Sweden 1998, 21-24 June. Hum Reprod 1998; 13 (Abstract Bk.1); 58.
9. Devroey P, Tournaye H, Van Steirteghem A, Hendrix P, Out HJ. The use of a 100 IU starting dose of recombinant follicle stimulating hormone (Puregon) in in-vitro fertilization. Hum Reprod 1998; 13: 565-566.
10. Out HJ, Lindenberg S, Mikkelsen AL et al. A prospective, randomized, double-blind clinical trial to study the efficacy and efficiency of a fixed dose of recombinant follicle stimulating hormone (Puregon) in women undergoing ovarian stimulation. Hum Reprod 1999; 14: 622-627.
11. Oliveness F & Frydman R. Friendly IVF: The way of the future? Hum Reprod 1998; 13: 1121-1124.